Judge Murphy held that wholesale removal of 17 ACIP experts and installation of largely non-expert replacements failed FACA “fair balance” and committee charter expertise requirements. The injunction ...

Many hospitalized adults could benefit from linkage to dental care. This article describes a planned study to refer inpatients to community dental providers. Objectives: Previous research suggests ...

Subcutaneous mosunetuzumab simplifies the delivery of the bispecific therapy for patients with relapsed/refractory follicular lymphoma, says Zahra Mahmoudjafari, PharmD, MBA, BCOP. “[The] mechanism is ...

University of California, San Diego.

Manuscripts are due July 31, 2026, for a January 2027 health IT special issue curated by guest editor Paige Nong, PhD, University of Minnesota. Emphasis is placed on rigorous evidence to guide ...

Time-varying adherence to five lifestyle domains after hypertension onset correlated with long-term cardiometabolic outcomes, enabling risk stratification beyond blood pressure control. Achieving an ...

Sharon Nachman, MD, is chief of the Division of Pediatric Infectious Disease, Stony Brook Children's Hospital, New York. Vaccine schedule shifts may widen gaps; learn how safety-net workflows and ...

Division of Infectious Diseases at Vanderbilt University School of Medicine, Nashville, Tennessee. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

Vaccine schedule shifts may widen gaps; learn how safety-net workflows and community education counter misinformation and boost uptake. As sweeping changes to the childhood vaccine schedule create ...

FDA rejection was attributed to a lack of substantial evidence of efficacy, including inconsistencies that undermined confidence in reproducibility across investigations. Reproxalap targets reactive ...

Serial PFAS biomonitoring at delivery and ages 3, 8, and 12 enabled assessment of exposure windows against DXA-derived BMD at six skeletal sites at age 12. PFOA showed the most consistent signal, with ...

BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...